Back to results
US 2025/0352566 A1Published application
Rhamnolipids for wound healing
AssigneeStepan Company
InventorsKelly Strout, Jesse Jefferis
Life of this patent
Estimating the term…
Abstract
The technology presented herein, in general, relates to the use of biosurfactants, such as rhamnolipids, for treating and/or accelerating the healing of wounds. More particularly, the present technology relates to a method for treating wounds, by applying a composition comprising a mixture of particular rhamnolipids to the wound, wherein application of the composition facilitates coordinated gene expression associated with wound healing.
Claims20
A composition for use in a method of treating a wound, the composition comprising:
- (a) a mixture of rhamnolipids, wherein the mixture of rhamnolipids comprises:
- mono-rhamnolipids and di-rhamnolipids in a weight ratio of about 40:60 to about 60:40 mono-rhamnolipids:
- di-rhamnolipids;
- an amount of C10-C10 mono-rhamnolipid of about 29% to about 40% by weight, based on the total weight of rhamnolipids present in the composition;
- an amount of C10-C10 di-rhamnolipid of about 35% to about 50% by weight, based on the total weight of rhamnolipids present in the composition;
- an amount of C8-C10 mono-rhamnolipid of about 2% to about 5% by weight, based on the total weight of rhamnolipids present in the composition;
- an amount of C8-C10 di-rhamnolipid of about 2% to about 5% by weight, based on the total weight of rhamnolipids present in the composition;
- an amount of C10-C12 mono-rhamnolipid of about 2% to about 6% by weight, based on the total weight of rhamnolipids present in the composition;
- and
- an amount of C10-C12 di-rhamnolipid of about 8% to about 14% by weight, based on the total weight of rhamnolipids present in the composition;
- (b) at least one acceptable carrier, and optionally one or more additives, in an amount to total 100% by weight of the composition.
8 more elements
A wound care composition, comprising:
- (a) a mixture of rhamnolipids, wherein the mixture of rhamnolipids comprises:
- mono-rhamnolipids and di-rhamnolipids in a weight ratio of about 40:60 to about 50:50 mono-rhamnolipids:
- di-rhamnolipids;
- an amount of C10-C10 mono-rhamnolipid of about 29% to about 37% by weight, based on the total weight of rhamnolipids present in the composition;
- an amount of C10-C10 di-rhamnolipid of about 35% to about 50% by weight, based on the total weight of rhamnolipids present in the composition;
- an amount of C8-C10 mono-rhamnolipid of about 2% to about 5% by weight, based on the total weight of rhamnolipids present in the composition;
- an amount of C8-C10 di-rhamnolipid of about 2% to about 5% by weight, based on the total weight of rhamnolipids present in the composition;
- an amount of C10-C12 mono-rhamnolipid of about 2% to about 6% by weight, based on the total weight of rhamnolipids present in the composition;
- and
- an amount of C10-C12 di-rhamnolipid of about 8% to about 14% by weight, based on the total weight of rhamnolipids present in the composition;
- (b) at least one acceptable carrier, and optionally one or more additives, in an amount to total 100% by weight of the composition.
8 more elements
Dependencies are inferred from the claim text.